Coronary Artery Disease (CAD) is prevalent in India, posing risks like heart attacks if untreated. Drug-Eluting Stents (DES) ...
Despite the impressive benefits obtained following the introduction of the drug-eluting stent, safety concerns have been raised over their long-term safety with particular regard to stent thrombosis.
Iron bioresorbable scaffold achieves noninferior angiographic and clinical outcomes versus drug eluting stent at 2 years in ...
Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a ...
A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary artery. The metal is coated in medicine and helps reopen your artery and keep it open. Stents are used to treat ...
Hosted on MSN
Drug-eluting balloon may be as safe, effective as conventional stents for repeat percutaneous coronary interventions
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
CHICAGO – Compared with a bare-metal stent, the use of a stent with a biodegradable polymer that releases the drug biolimus resulted in a lower rate of major adverse cardiac events at 1 year among ...
Please provide your email address to receive an email when new articles are posted on . A novel coronary scaffold technology was noninferior to a drug-eluting stent for target lesion failure at 12 ...
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA) ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A bioadaptor implant was linked to fewer CV event rates ...
Research suggests flexible approach to antiplatelet management after drug-eluting stent implantation
Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or major bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results